Journal article

Real-world adherence, persistence, and in-class switching during use of dipeptidyl peptidase-4 inhibitors: a systematic review and meta-analysis involving 594,138 patients with type 2 diabetes

Oyepeju Ogundipe, Mohsen Mazidi, Ken Lee Chin, Deval Gor, Andrew McGovern, Berhe W Sahle, Gyorgy Jermendy, Maarit Jaana Korhonen, Bernard Appiah, Zanfina Ademi, Marie Louise De Bruin, Danny Liew, Richard Ofori-Asenso

Acta Diabetologica | SPRINGER-VERLAG ITALIA SRL | Published : 2020


AIMS: Medication adherence and persistence are important determinants of treatment success in type 2 diabetes mellitus (T2DM). This systematic review and meta-analysis evaluated the real-world adherence, persistence, and in-class switching among patients with T2DM prescribed dipeptidyl peptidase-4 (DPP4) inhibitors. METHODS: MEDLINE, EMBASE, Cochrane Library, PsychINFO, and CINAHL were searched for relevant observational studies published in the English language up to 20 December 2019. This was supplemented by manual screening of the references of included papers. Random-effects meta-analysis was performed. RESULTS: Thirty-four cohort studies involving 594,138 patients with T2DM prescribed D..

View full abstract